Literature DB >> 19845032

Histiocytic sarcoma with interdigitating dendritic cell differentiation: a case report with fine needle aspiration cytology and review of literature.

Grace C H Yang1, Carrie E Besanceney, Wayne Tam.   

Abstract

A hybrid histiocytic sarcoma-interdigitating dendritic cell sarcoma was found in a small perinephric lymph node of an asymptomatic 80-year-old man, who presented a year ago with two small foci of lung metastasis found during routine chest X-ray. Fine needle aspiration cytology demonstrated interconnecting long and thin cell processes radiating from dendrite-like neoplastic cells with oval, enlongated, reniform, and irregular nuclei with vesicular chromatin and distinct nucleoli. Histology showed spindled epitheliod and histiocytic cells with abundant, slightly eosinophilic cytoplasm with indistinct cell borders and forming fascicles in a vague storiform pattern with interspersed T-lymphocytes. Immunohistochemically, the neoplastic cells were strongly positive for histiocytic markers: CD163, CD68, lysozyme, and PU.1, as well as strongly positive for dendritic cell markers: S100 and fascin, but were negative for CD1a (Langerhans cell marker), CD21/CD35 (follicular dendritic cell markers), B-cell, and T cell markers. This case is compared to the four hybrid histiocytic-dendritic sarcomas reported since 1983.

Entities:  

Mesh:

Year:  2010        PMID: 19845032     DOI: 10.1002/dc.21215

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  6 in total

1.  Histiocytic sarcoma with two immunohistopathologically distinct populations.

Authors:  Kanako Wakahashi; Manabu Shimoyama; Yoshio Katayama; Kentaro Minagawa; Kenji Yoshida; Ryohei Sasaki; Shunji Nakayama; Hiroshi Yokozaki; Emmy Yanagita; Tomoo Itoh; Yoshitake Hayashi; Toshimitsu Matsui
Journal:  Int J Hematol       Date:  2010-10-06       Impact factor: 2.490

2.  Targeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasone.

Authors:  Jonas H Graversen; Pia Svendsen; Frederik Dagnæs-Hansen; Jakob Dal; Gabriele Anton; Anders Etzerodt; Mikkel D Petersen; Peter A Christensen; Holger J Møller; Søren K Moestrup
Journal:  Mol Ther       Date:  2012-05-29       Impact factor: 11.454

3.  A case of interdigitating dendritic cell sarcoma/histiocytic sarcoma--a diagnostic pitfall.

Authors:  Rebecca L Johnson; Saskia Boisot; Edward D Ball; Huan-You Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 4.  Interdigitating dendritic cell sarcoma presenting simultaneously with acute myelomonocytic leukemia: report of a rare case and literature review.

Authors:  Yi-Zhi Jiang; Ning-Zheng Dong; De-Pei Wu; Sheng-Li Xue
Journal:  Int J Hematol       Date:  2013-04-19       Impact factor: 2.490

5.  Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.

Authors:  Lucas R Massoth; Yin P Hung; Lawrence R Zukerberg; Erik A Williams; Judith A Ferry; Robert P Hasserjian; Valentina Nardi; G Petur Nielsen; Sam Sadigh; Vinayak Venkataraman; Martin Selig; Alison M Friedmann; Wesley Samore; Jonathan Keith Killian; Riza Milante; Joseph Giessinger; Kathleen Foley-Peres; Chelsea Marcus; Eric Severson; Daniel Duncan; Smruthy Sivakumar; Jeffrey S Ross; Vikram Desphande; Shakti H Ramkissoon; Jo-Anne Vergilio; Abner Louissaint
Journal:  Oncologist       Date:  2021-05-06

6.  Histological and immunohistochemical studies on primary intracranial canine histiocytic sarcomas.

Authors:  Atigan Thongtharb; Kazuyuki Uchida; James Kenn Chambers; Yumiko Kagawa; Hiroyuki Nakayama
Journal:  J Vet Med Sci       Date:  2015-12-12       Impact factor: 1.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.